ACET
Price
$0.80
Change
+$0.02 (+2.56%)
Updated
Jun 4, 04:59 PM (EDT)
Capitalization
65.42M
63 days until earnings call
BFRI
Price
$0.62
Change
-$0.04 (-6.06%)
Updated
Jun 4, 04:57 PM (EDT)
Capitalization
9.77M
Interact to see
Advertisement

ACET vs BFRI

Header iconACET vs BFRI Comparison
Open Charts ACET vs BFRIBanner chart's image
Adicet Bio
Price$0.80
Change+$0.02 (+2.56%)
Volume$2.99K
Capitalization65.42M
Biofrontera
Price$0.62
Change-$0.04 (-6.06%)
Volume$2K
Capitalization9.77M
ACET vs BFRI Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. BFRI commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a StrongBuy and BFRI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (ACET: $0.79 vs. BFRI: $0.63)
Brand notoriety: ACET and BFRI are both not notable
ACET represents the Biotechnology, while BFRI is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 50% vs. BFRI: 109%
Market capitalization -- ACET: $65.42M vs. BFRI: $9.77M
ACET [@Biotechnology] is valued at $65.42M. BFRI’s [@Pharmaceuticals: Other] market capitalization is $9.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whileBFRI’s FA Score has 1 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • BFRI’s FA Score: 1 green, 4 red.
According to our system of comparison, ACET is a better buy in the long-term than BFRI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 7 TA indicator(s) are bullish while BFRI’s TA Score has 5 bullish TA indicator(s).

  • ACET’s TA Score: 7 bullish, 2 bearish.
  • BFRI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ACET is a better buy in the short-term than BFRI.

Price Growth

ACET (@Biotechnology) experienced а +21.13% price change this week, while BFRI (@Pharmaceuticals: Other) price change was +2.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.56%. For the same industry, the average monthly price growth was +5.22%, and the average quarterly price growth was -1.09%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +73.69%. For the same industry, the average monthly price growth was +15.08%, and the average quarterly price growth was +62.67%.

Reported Earning Dates

ACET is expected to report earnings on Aug 06, 2025.

BFRI is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+6.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (+73.69% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACET($65.4M) has a higher market cap than BFRI($9.77M). ACET YTD gains are higher at: -19.023 vs. BFRI (-39.009). BFRI has higher annual earnings (EBITDA): -18.45M vs. ACET (-110.82M). ACET has more cash in the bank: 150M vs. BFRI (1.42M). BFRI has less debt than ACET: BFRI (5.4M) vs ACET (16.2M). BFRI has higher revenues than ACET: BFRI (34.1M) vs ACET (0).
ACETBFRIACET / BFRI
Capitalization65.4M9.77M669%
EBITDA-110.82M-18.45M601%
Gain YTD-19.023-39.00949%
P/E RatioN/AN/A-
Revenue034.1M-
Total Cash150M1.42M10,556%
Total Debt16.2M5.4M300%
FUNDAMENTALS RATINGS
ACET: Fundamental Ratings
ACET
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
17
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACETBFRI
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 21 days ago
88%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIEZX16.22N/A
N/A
GuideStone Funds International Eq Inv
OIGAX34.95N/A
N/A
Invesco Oppenheimer International Gr A
NSFEX10.57N/A
N/A
Natixis Target Retirement 2025 N
JNVYX18.38N/A
N/A
Jensen Quality Mid Cap Y
TIHIX13.59N/A
N/A
Transamerica International Stock I2

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+4.01%
OGI - ACET
41%
Loosely correlated
+1.53%
RGNX - ACET
40%
Loosely correlated
-2.13%
DVAX - ACET
39%
Loosely correlated
+1.73%
ARWR - ACET
39%
Loosely correlated
+1.28%
SLDB - ACET
37%
Loosely correlated
-1.13%
More

BFRI and

Correlation & Price change

A.I.dvisor tells us that BFRI and ACET have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
+16.26%
ACET - BFRI
25%
Poorly correlated
+4.01%
DVAX - BFRI
23%
Poorly correlated
+1.73%
HCM - BFRI
23%
Poorly correlated
+8.09%
LNTH - BFRI
23%
Poorly correlated
+0.73%
EVO - BFRI
23%
Poorly correlated
+1.26%
More